Scientists hunt for hidden clues to personalize cancer radiotherapy
NCT ID NCT07232680
Summary
This study aims to find biological markers that can predict how well patients with nasopharyngeal cancer (NPC) respond to radiotherapy and what side effects they might experience. It will follow 500 patients with early to mid-stage NPC who are receiving either proton or photon radiotherapy, along with chemotherapy. Researchers will analyze scans and blood samples over two years to identify patterns linked to survival, cancer control, and treatment safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CANCINOMA (NPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chang Gung Memorial Hospital at Linkou
RECRUITINGTaoyuan, Taiwan, 333, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.